HALO
Price
$91.35Alerts
Change
-$1.69 (-1.82%)
Updated
Nov 20 closing price
Capitalization
11.76B
93 days until earnings call
Intraday BUY SELL Signals
RPRX
Price
$68.45Alerts
Change
+$0.73 (+1.08%)
Updated
Nov 20 closing price
Capitalization
29.97B
86 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

HALO vs RPRX

HALO vs RPRX Comparison Chart in %
View a ticker or compare two or three
VS
HALO vs. RPRX commentary
Nov 22, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HALO is a Hold and RPRX is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for HALO with price predictions
Nov 20, 2026

HALO in +2.09% Uptrend, growing for three consecutive days on October 29, 2026

Moving higher for three straight days is viewed as a bullish sign. Keep an eye on this stock for future growth. Considering data from situations where HALO advanced for three days, in 276 of 335 cases, the price rose further within the following month. The odds of a continued upward trend are 82%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

HALO may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In 244 of 328 cases where HALO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 74%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on November 05, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on HALO as a result. In 49 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 64%.

The Moving Average Convergence Divergence Histogram (MACD) for HALO turned negative on November 05, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 36 similar instances when the indicator turned negative. In 24 of the 36 cases the stock turned lower in the days that followed. This puts the odds of success at 67%.

HALO moved below its 50-day moving average on November 06, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for HALO crossed bearishly below the 50-day moving average on November 13, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 8 of 13 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 62%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where HALO declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 60%.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 6 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is 11 (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 29 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 57 (best 1 - 100 worst), indicating steady price growth. HALO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 98 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: HALO's P/B Ratio (81.939) is slightly higher than the industry average of (3.596). P/E Ratio (29.192) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (0.040) is also within normal values, averaging (9.158). Dividend Yield (0.000) settles around the average of (131.631) among similar stocks. P/S Ratio (7.968) is also within normal values, averaging (443.347).

A.I.Advisor
a Summary for RPRX with price predictions
Nov 20, 2026

Aroon Indicator for RPRX shows an upward move is likely

RPRX's Aroon Indicator triggered a bullish signal on November 20, 2026. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 268 similar instances where the Aroon Indicator showed a similar pattern. In 188 of the 268 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at 70%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

RPRX moved above its 50-day moving average on October 15, 2026 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for RPRX crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 9 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 60%.

Following a +1.80% 3-day Advance, the price is estimated to grow further. Considering data from situations where RPRX advanced for three days, in 174 of 313 cases, the price rose further within the following month. The odds of a continued upward trend are 56%.

Bearish Trend Analysis

The 10-day RSI Indicator for RPRX moved out of overbought territory on November 16, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 31 similar instances where the indicator moved out of overbought territory. In 16 of the 31 cases, the stock moved lower in the following days. This puts the odds of a move lower at 52%.

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 35 of 68 cases where RPRX's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 51%.

The Moving Average Convergence Divergence Histogram (MACD) for RPRX turned negative on November 17, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 51 similar instances when the indicator turned negative. In 26 of the 51 cases the stock turned lower in the days that followed. This puts the odds of success at 51%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where RPRX declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 49%.

RPRX broke above its upper Bollinger Band on October 20, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 8 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is 14 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

The Tickeron Price Growth Rating for this company is 36 (best 1 - 100 worst), indicating steady price growth. RPRX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of 91 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.386) is normal, around the industry mean (3.596). P/E Ratio (35.989) is within average values for comparable stocks, (-1.186). Projected Growth (PEG Ratio) (1.360) is also within normal values, averaging (9.158). Dividend Yield (0.014) settles around the average of (131.631) among similar stocks. P/S Ratio (12.870) is also within normal values, averaging (443.347).

The Tickeron SMR rating for this company is 97 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

FUNDAMENTALS RATINGS
HALO vs RPRX: Fundamental Ratings
HALO
RPRX
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
98
Overvalued
91
Overvalued
PROFIT vs RISK RATING
1..100
2914
SMR RATING
1..100
1197
PRICE GROWTH RATING
1..100
5736
P/E GROWTH RATING
1..100
68
SEASONALITY SCORE
1..100
n/a75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

RPRX's Valuation (91) in the Pharmaceuticals Major industry is in the same range as HALO (98) in the Biotechnology industry. This means that RPRX’s stock grew similarly to HALO’s over the last 12 months.

RPRX's Profit vs Risk Rating (14) in the Pharmaceuticals Major industry is in the same range as HALO (29) in the Biotechnology industry. This means that RPRX’s stock grew similarly to HALO’s over the last 12 months.

HALO's SMR Rating (11) in the Biotechnology industry is significantly better than the same rating for RPRX (97) in the Pharmaceuticals Major industry. This means that HALO’s stock grew significantly faster than RPRX’s over the last 12 months.

RPRX's Price Growth Rating (36) in the Pharmaceuticals Major industry is in the same range as HALO (57) in the Biotechnology industry. This means that RPRX’s stock grew similarly to HALO’s over the last 12 months.

HALO's P/E Growth Rating (6) in the Biotechnology industry is in the same range as RPRX (8) in the Pharmaceuticals Major industry. This means that HALO’s stock grew similarly to RPRX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
HALORPRX
RSI
ODDS (%)
Bullish Trend 3 days ago
67%
Bearish Trend 3 days ago
52%
Stochastic
ODDS (%)
Bullish Trend 3 days ago
75%
Bearish Trend 3 days ago
51%
Momentum
ODDS (%)
Bearish Trend 3 days ago
64%
N/A
MACD
ODDS (%)
Bearish Trend 3 days ago
67%
Bearish Trend 3 days ago
51%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
61%
Bearish Trend 3 days ago
53%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
64%
Bullish Trend 3 days ago
60%
Advances
ODDS (%)
Bullish Trend 25 days ago
82%
Bullish Trend 12 days ago
56%
Declines
ODDS (%)
Bearish Trend 3 days ago
60%
Bearish Trend 4 days ago
49%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
63%
Bearish Trend 4 days ago
56%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
70%
COMPARISON
Comparison
Nov 22, 2026
Stock price -- (HALO: $91.35 vs. RPRX: $68.45)
Brand notoriety: HALO and RPRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: HALO: 54% vs. RPRX: 106%
Market capitalization -- HALO: $11.76B vs. RPRX: $29.97B
HALO [@Biotechnology] is valued at $11.76B. RPRX’s [@Biotechnology] market capitalization is $29.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $58 to $138.67B. The average market capitalization across the [@Biotechnology] industry is $2.24B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

HALO’s FA Score shows that 3 FA rating(s) are green while RPRX’s FA Score has 2 green FA rating(s).

  • HALO’s FA Score: 3 green, 2 red.
  • RPRX’s FA Score: 2 green, 3 red.
According to our system of comparison, HALO is a better buy in the long-term than RPRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

HALO’s TA Score shows that 5 TA indicator(s) are bullish while RPRX’s TA Score has 4 bullish TA indicator(s).

  • HALO’s TA Score: 5 bullish, 5 bearish.
  • RPRX’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, HALO is a better buy in the short-term than RPRX.

Price Growth

HALO (@Biotechnology) experienced а -8.90% price change this week, while RPRX (@Biotechnology) price change was -1.24% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -11.58%. For the same industry, the average monthly price growth was -18.26%, and the average quarterly price growth was -28.15%.

Reported Earning Dates

HALO is expected to report earnings on Feb 23, 2027.

RPRX is expected to report earnings on Feb 16, 2027.

Industries' Descriptions

@Biotechnology (-11.58% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

View a ticker or compare two or three
Interact to see
Advertisement

HALO and

Correlation & Price change

A.I.dvisor indicates that over the last year, HALO has been loosely correlated with AXON. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if HALO jumps, then AXON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To HALO
1D Price
Change %
HALO100%
-1.82%
AXON - HALO
47%
Loosely correlated
-5.16%
VRTX - HALO
37%
Loosely correlated
-1.08%
INCY - HALO
36%
Loosely correlated
-1.07%
VCYT - HALO
34%
Loosely correlated
+0.36%
RPRX - HALO
34%
Loosely correlated
+1.08%
More

RPRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RPRX has been loosely correlated with INCY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if RPRX jumps, then INCY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RPRX
1D Price
Change %
RPRX100%
+1.08%
INCY - RPRX
51%
Loosely correlated
-1.07%
VRTX - RPRX
50%
Loosely correlated
-1.08%
AXON - RPRX
48%
Loosely correlated
-5.16%
REGN - RPRX
44%
Loosely correlated
-0.19%
EXEL - RPRX
37%
Loosely correlated
-1.82%
More
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
IBMT25.320.05
+0.18%
iShares iBonds Dec 2031 Term Muni Bond ETF (IBMT)
IWM256.61-7.61
-2.88%
iShares Russell 2000 ETF (IWM)
LOPP33.14-1.09
-3.20%
Gabelli Love Our Planet & People ETF (LOPP)
XDSQ40.17-1.73
-4.13%
Innovator US Equity Accelerated ETF (XDSQ)
ATFV30.45-2.00
-6.18%
Alger 35 ETF (ATFV)